Reuters logo
BRIEF-MacroGenics' MGd006 granted orphan drug status for AML by FDA
January 5, 2017 / 10:36 PM / in a year

BRIEF-MacroGenics' MGd006 granted orphan drug status for AML by FDA

Jan 5 (Reuters) - Macrogenics Inc :

* Macrogenics’ MGD006 granted orphan drug status for AML by fda

* Macrogenics Inc says retains full development and commercialization rights to mgd006 in U.S., Canada, Mexico, Japan, South Korea and India Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below